CGMP/Finished Pharmaceuticals/Adulterated
Similar Posts
Expanded Access to Investigational Drugs for Treatment Use – Questions and Answers – 04/15/2026
An informative webinar on the FDA guidance Expanded Access to Investigational Drugs for Treatment Use: Questions and AnswersCentral Admixture Pharmacy Services, Inc., (CAPS), Livonia, MI, 483 Issued 2/28/2013
Central Admixture Pharmacy Services, Inc., (CAPS), Livonia, MI, 483 Issued 2/28/2013Fusion IV Pharmaceuticals Inc. dba Axia Pharmaceuticals, Los Angeles, CA. 483, Second Amended 483 Issued 03/23/2017
Task Description Request Please post to the 2017 Pharmacy Inspections and Related Records Web page
Record Date 03/23/2017
FEI Number 3013341563
Firm Name Fusion IV Pharmaceuticals Inc. dba Axia Pharmaceutical
Record Type 483
State CA
Establishment Type Producer of Sterile Drug ProductsEarly Alert: Blood Pump Controller Issue from Abiomed
This communication is part of the Communications Pilot to Enhance the Medical Device Recall ProgramBlue Bell Ice Cream Issues Allergy Alert on Undeclared Almond, Walnut, and Pecan in Moo-llennium Crunch Ice Cream Packaged in a Chocolate Chip Cookie Dough Half Gallon Carton with a Moo-llennium Crunch Ice Cream Lid
BRENHAM, Texas, August 22, 2025 – Blue Bell Ice Cream is voluntarily recalling a limited quantity of Moo-llennium Crunch Ice Cream half gallon packaged in a Chocolate Chip Cookie Dough carton produced in its Brenham, Texas, plant because of undeclared almond, walnut, and pecan. The recalled productMelcare Biomedical Pty Ltd – 717968 – 10/09/2025
Nonprescription/OTC.”